skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 3,402  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: List of all Versions The American Heart Journal remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
Material Type:
Article
Add to My Research

Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial

The American heart journal, 2016-03, Vol.173, p.94-101 [Peer Reviewed Journal]

Mosby, Inc. ;2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Mar 1, 2016 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2015.11.015 ;PMID: 26920601

Full text available

2
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
Material Type:
Article
Add to My Research

Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design

The American heart journal, 2020-11, Vol.229, p.61-69 [Peer Reviewed Journal]

2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved. ;2020. The Author(s) ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2020.07.008 ;PMID: 32916609

Full text available

3
Medication adherence: A call for action
Material Type:
Article
Add to My Research

Medication adherence: A call for action

The American heart journal, 2011-09, Vol.162 (3), p.412-424 [Peer Reviewed Journal]

Mosby, Inc. ;2011 Mosby, Inc. ;2015 INIST-CNRS ;Copyright © 2011 Mosby, Inc. All rights reserved. ;Copyright Elsevier Limited Sep 2011 ;ISSN: 0002-8703 ;ISSN: 1097-6744 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2011.06.007 ;PMID: 21884856 ;CODEN: AHJOA2

Full text available

4
Rheumatoid arthritis and cardiovascular disease
Material Type:
Article
Add to My Research

Rheumatoid arthritis and cardiovascular disease

The American heart journal, 2013-10, Vol.166 (4), p.622-628.e1 [Peer Reviewed Journal]

Mosby, Inc. ;2013 Mosby, Inc. ;2013 Mosby, Inc. All rights reserved. ;Copyright Elsevier Limited Oct 2013 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2013.07.010 ;PMID: 24093840 ;CODEN: AHJOA2

Full text available

5
ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes
Material Type:
Article
Add to My Research

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes

The American heart journal, 2018-04, Vol.198, p.135-144 [Peer Reviewed Journal]

2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Apr 2018 ;2017 The Authors 2017 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2017.12.006 ;PMID: 29653635

Full text available

6
Changes in comorbidities, diagnoses, therapies and outcomes in a contemporary cardiac intensive care unit population
Material Type:
Article
Add to My Research

Changes in comorbidities, diagnoses, therapies and outcomes in a contemporary cardiac intensive care unit population

The American heart journal, 2019-09, Vol.215, p.12-19 [Peer Reviewed Journal]

2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;2019. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2019.05.012 ;PMID: 31260901

Full text available

7
Out-of-pocket prescription drug costs for adults with cardiovascular risk factors under Amazon's direct-to-consumer pharmacy service
Material Type:
Article
Add to My Research

Out-of-pocket prescription drug costs for adults with cardiovascular risk factors under Amazon's direct-to-consumer pharmacy service

The American heart journal, 2024-05, Vol.271, p.20-27 [Peer Reviewed Journal]

2024 Elsevier Inc. ;Copyright © 2024 Elsevier Inc. All rights reserved. ;2024. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2024.02.004 ;PMID: 38365072

Digital Resources/Online E-Resources

8
Effect of rosuvastatin 20 mg versus rosuvastatin 5 mg plus ezetimibe on statin side-effects in elderly patients with atherosclerotic cardiovascular disease: Rationale and design of a randomized, controlled SaveSAMS trial
Material Type:
Article
Add to My Research

Effect of rosuvastatin 20 mg versus rosuvastatin 5 mg plus ezetimibe on statin side-effects in elderly patients with atherosclerotic cardiovascular disease: Rationale and design of a randomized, controlled SaveSAMS trial

The American heart journal, 2023-07, Vol.261, p.45-50 [Peer Reviewed Journal]

2023 Elsevier Inc. ;Copyright © 2023 Elsevier Inc. All rights reserved. ;2023. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2023.03.002 ;PMID: 36934981

Full text available

9
Intensity of and adherence to lipid-lowering therapy as predictors of goal attainment and major adverse cardiovascular events in primary prevention
Material Type:
Article
Add to My Research

Intensity of and adherence to lipid-lowering therapy as predictors of goal attainment and major adverse cardiovascular events in primary prevention

The American heart journal, 2024-03, Vol.269, p.118-130 [Peer Reviewed Journal]

2023 The Author(s) ;Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved. ;2023. The Author(s) ;ISSN: 0002-8703 ;ISSN: 1097-6744 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2023.12.010 ;PMID: 38109988

Full text available

10
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE
Material Type:
Article
Add to My Research

Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE

The American heart journal, 2023-10, Vol.264, p.31-39 [Peer Reviewed Journal]

2023 ;Copyright © 2023. Published by Elsevier Inc. ;Copyright Elsevier Limited Oct 2023 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2023.06.001 ;PMID: 37290700

Full text available

11
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial
Material Type:
Article
Add to My Research

Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial

The American heart journal, 2024-03, Vol.269, p.179-190 [Peer Reviewed Journal]

2024 Elsevier Inc. ;Copyright © 2024 Elsevier Inc. All rights reserved. ;2024. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2023.12.004 ;PMID: 38160917

Full text available

12
Smoking cessation and risk of recurrent cardiovascular events and mortality after a first manifestation of arterial disease
Material Type:
Article
Add to My Research

Smoking cessation and risk of recurrent cardiovascular events and mortality after a first manifestation of arterial disease

The American heart journal, 2019-07, Vol.213, p.112-122 [Peer Reviewed Journal]

2019 The Authors ;Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;2019. The Authors ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2019.03.019 ;PMID: 31132583

Full text available

13
Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial
Material Type:
Article
Add to My Research

Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial

The American heart journal, 2013-11, Vol.166 (5), p.823-830.e5 [Peer Reviewed Journal]

Mosby, Inc. ;2013 Mosby, Inc. ;2013. ;Copyright Elsevier Limited Nov 2013 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2013.07.012 ;PMID: 24176437 ;CODEN: AHJOA2

Full text available

14
Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease
Material Type:
Article
Add to My Research

Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease

The American heart journal, 2022-07, Vol.249, p.12-22 [Peer Reviewed Journal]

2022 Elsevier Inc. ;Copyright © 2022 Elsevier Inc. All rights reserved. ;2022. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2022.03.006 ;PMID: 35318028

Full text available

15
The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics
Material Type:
Article
Add to My Research

The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics

The American heart journal, 2019-12, Vol.218, p.46-56 [Peer Reviewed Journal]

2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;2019. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2019.09.011 ;PMID: 31706144

Full text available

16
Socioeconomic disparities in healthcare utilization for atherosclerotic cardiovascular disease
Material Type:
Article
Add to My Research

Socioeconomic disparities in healthcare utilization for atherosclerotic cardiovascular disease

The American heart journal, 2022-04, Vol.246, p.161-165 [Peer Reviewed Journal]

2022 Elsevier Inc. ;Copyright © 2022 Elsevier Inc. All rights reserved. ;2022. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2022.01.011 ;PMID: 35093303

Full text available

17
Modeling the cost effectiveness and budgetary impact of Polypills for secondary prevention of cardiovascular disease in the United States
Material Type:
Article
Add to My Research

Modeling the cost effectiveness and budgetary impact of Polypills for secondary prevention of cardiovascular disease in the United States

The American heart journal, 2019-08, Vol.214, p.77-87 [Peer Reviewed Journal]

2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;2019. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2019.04.020 ;PMID: 31174054

Full text available

18
Rationale and design of a nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention trial (EXTRA-CVD)
Material Type:
Article
Add to My Research

Rationale and design of a nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention trial (EXTRA-CVD)

The American heart journal, 2019-10, Vol.216, p.91-101 [Peer Reviewed Journal]

2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;2019. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2019.07.005 ;PMID: 31419622

Full text available

19
Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study
Material Type:
Article
Add to My Research

Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study

The American heart journal, 2014-12, Vol.168 (6), p.878-883.e1 [Peer Reviewed Journal]

Elsevier Inc. ;2014 Elsevier Inc. ;Copyright © 2014 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Dec 2014 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2014.08.007 ;PMID: 25458651 ;CODEN: AHJOA2

Full text available

20
Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease
Material Type:
Article
Add to My Research

Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease

The American heart journal, 2019-12, Vol.218, p.92-99 [Peer Reviewed Journal]

2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;2019. Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2019.09.013 ;PMID: 31715435

Full text available

Results 1 - 20 of 3,402  for All Library Resources

Results 1 2 3 4 5 next page

Searching Remote Databases, Please Wait